Boots Introduces In-Store Weight Loss Jab Service, Enhancing Accessibility for Customers

Emily Watson, Health Editor
5 Min Read
⏱️ 3 min read

In a significant development for weight management in the UK, Boots has launched a new in-store service that allows customers to receive weight loss injections during a face-to-face consultation. This pilot scheme, initiated this week, is available in 17 locations across the country, including major cities such as London, Manchester, and Edinburgh. The move aims to improve accessibility for the estimated 1.6 million adults in the UK currently using weight-loss medications.

Enhancing Accessibility and Convenience

Previously, patients seeking prescriptions for medications like Wegovy and Mounjaro had to rely on online consultations. However, the new initiative allows users to visit a Boots pharmacy and consult with a qualified healthcare professional in a private setting. During this consultation, their medical history will be reviewed, and their height and weight will be measured to assess eligibility for the injections.

Jamie Kerruish, Boots’ Chief Healthcare Officer, highlighted the convenience of this new service, allowing individuals to “pop into a store on their lunch break or after work.” This shift towards in-person consultations responds to safety concerns about the potential for dishonesty in online assessments, where some individuals may have submitted inaccurate information to obtain prescriptions from online pharmacies.

Addressing the Growing Demand for Weight-Loss Treatments

Weight-loss injections, classified as GLP-1 receptor agonists, have surged in popularity as a means to combat obesity. In the UK, to qualify for these medications through the NHS, a patient must have a Body Mass Index (BMI) of 40 or higher. Private providers, however, extend this eligibility to individuals with a BMI of 30 or more, resulting in a burgeoning demand for these treatments outside the NHS.

Addressing the Growing Demand for Weight-Loss Treatments

Boots has been offering Wegovy, produced by Novo Nordisk, for three years and has recently added Mounjaro, which is also available through the NHS. Prices for these medications start at £99.97 for the lowest dosage of Wegovy and £176.97 for Mounjaro. The in-store service will mirror the offerings of the Boots Online Doctor service, maintaining consistent pricing and treatment options.

Comprehensive Support for Weight Management

In addition to administering weight-loss injections, the Boots service is designed to provide holistic support for individuals affected by obesity. Kerruish noted that the initiative aims to cater to varying preferences among patients, acknowledging that some may prefer online interactions while others seek in-person discussions with healthcare practitioners.

This dual approach not only facilitates access to medication but also encourages lifestyle and behavioural changes that are vital for long-term weight management success. The Boots team is committed to helping patients navigate their health journeys with tailored support and guidance.

Locations Offering the New Service

The following Boots locations will provide this innovative weight-loss treatment service:

Locations Offering the New Service

– Nottingham, Victoria Centre

– Cardiff, Queen Street

– Durham, Market Place

– Belfast, Donegal Place

– Edinburgh, Princes Street

– Newcastle, Sidgate

– St Albans, St Peters Street

– London, Liverpool Street Station

– Leicester, Fosse Park

– Brighton, North Street

– London, Piccadilly Circus

– Dartford, Blue Water

– Altrincham, Stamford Quarter

– Chester-Le-Street, County Durham

– Middlesbrough, Nunthorpe

– Bath, Southgate Centre

– Lisburn, Sprucefield

Why it Matters

The introduction of in-store weight loss jab services by Boots represents a pivotal advancement in the accessibility of obesity treatment in the UK. By enabling face-to-face consultations, Boots not only addresses safety concerns but also personalises patient care, making it easier for individuals to seek help. This initiative is crucial as obesity rates continue to rise, underscoring the need for effective, accessible healthcare solutions that can adapt to the diverse preferences of patients seeking assistance in their weight loss journeys.

Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy